Your Anxiety Toolkit - Practical Skills for Anxiety, Panic & Depression 432 OCD Treatment in 2025: Updates in Research, Treatment & the Future (with Dr Jon Abramowitz)
May 5, 2025
Dr. Jon Abramowitz, a leading authority on OCD and a professor at UNC, delves into the advancements in OCD treatment by 2025. He discusses the effectiveness of exposure and response prevention (ERP) and emerging therapies like Acceptance and Commitment Therapy (ACT). Key challenges include misdiagnosis and the risks of AI inaccuracies in research. The conversation also sheds light on dismantling misconceptions surrounding OCD and emphasizes the importance of community support and tailored care for those affected.
AI Snips
Chapters
Books
Transcript
Episode notes
ERP: Proven but Needs Reach
- ERP is the gold standard treatment for OCD with increasing clinician training and resources.
- Despite progress, misdiagnosis and limited tailored approaches for diverse populations remain challenges.
Evaluating OCD Research Quality
- When evaluating OCD research, prioritize studies with large participant numbers and randomized controlled designs.
- Be cautious of small or non-blinded studies often promoted on social media as definitive.
ERP’s Long-Term Effectiveness
- Meta-analyses confirm ERP's lasting effectiveness for OCD across many studies.
- ERP improvements generally maintain at long-term follow-ups but do not fully cure OCD.